Informed consent is the process through which a person voluntarily authorizes a medical intervention or participation in research after receiving and understanding relevant information. In medicine, it connects communication with a patient’s decision about care; in research, it safeguards the freedom to decide whether to participate. It is a principle of ethics and law, rather than merely the act of signing a document. Valid consent ordinarily involves adequate disclosure, understanding, decision-making capacity, and voluntariness. (code-medical-ethics.ama-assn.org)
Ethical foundations and development
Informed consent expresses respect for patient autonomy: a person’s authority to make decisions about their own medical care or research participation. Respect for persons also includes protecting individuals whose ability to decide independently is limited. Consent therefore combines an opportunity for self-determination with safeguards against exploitation; it does not eliminate the separate obligation to assess whether research risks are justified. (hhs.gov)
Two influential research-ethics documents helped articulate these obligations. The Declaration of Helsinki, first adopted by the World Medical Association in June 1964, establishes ethical principles for medical research involving human participants. The United States’ Belmont Report, published in 1979, identifies respect for persons, beneficence, and justice as basic principles and analyzes consent in terms of information, comprehension, and voluntariness. These documents provide ethical frameworks, while particular legal requirements depend on the applicable jurisdiction and regulatory system. (wma.net)
Elements of valid consent
Disclosure concerns the information needed to make a meaningful choice. In clinical care, this includes the known diagnosis, the nature and purpose of the proposed intervention, and the burdens, risks, and expected benefits of available options, including forgoing treatment. The information concerns a specific decision rather than unrestricted permission for any future intervention. (code-medical-ethics.ama-assn.org)
Understanding requires more than receiving information. The Belmont Report emphasizes that organization, timing, opportunities for questions, and the person’s ability to comprehend affect the consent process. Technical terminology or a hurried presentation can impede comprehension. Information may need adaptation to the person’s maturity and language, and researchers bear responsibility for determining whether essential information has been understood. (hhs.gov)
Decision-making capacity concerns the ability to understand relevant information and the implications of alternatives sufficiently to make the decision involved. Consent procedures include assessing this ability, rather than assuming that disclosure alone establishes valid authorization. Where an individual cannot provide consent, an appropriately authorized representative may be involved under applicable rules. (code-medical-ethics.ama-assn.org)
Voluntariness means that authorization is given without coercion or undue influence. The Belmont Report distinguishes threats used to obtain compliance from improper inducements or controlling pressures. Relationships involving authority or dependence can require special safeguards, particularly when declining research might appear to threaten access to care. (hhs.gov)
Clinical care and research
In treatment, informed consent supports shared decision-making between patient and clinician. Discussion enables the patient to consider medically appropriate options in light of the information provided. The clinical record documents both the conversation and the decision; a written consent form, when used, forms part of that record rather than replacing the discussion. (code-medical-ethics.ama-assn.org)
In human-subjects research, consent must explain what participation entails and distinguish experimental procedures from ordinary care. Research disclosures address foreseeable risks, possible benefits, relevant alternatives, and conflicts of interest. Ethical guidance also calls for avoiding unrealistic expectations about benefit. Participation is not made ethically acceptable simply because an individual agrees to it. (code-medical-ethics.ama-assn.org)
For research covered by the United States’ revised Common Rule, required information includes the study’s purpose and duration, procedures, confidentiality protections, relevant contacts, and the voluntary nature of participation. Refusal or discontinuation must not entail penalties or loss of benefits to which the person is otherwise entitled. For studies involving more than minimal risk, disclosure also addresses compensation and available treatment for research-related injury. (hhs.gov)
Representatives, children, and exceptions
A legally authorized representative may provide research consent for someone unable to do so, subject to applicable requirements. The Declaration of Helsinki requires consideration of that person’s expressed preferences and values. In research involving children, parental or guardian permission and child assent are distinct protections. Assent means affirmative agreement, not merely failure to object; whether it is required depends on the governing rules and ethics review. (wma.net)
Clinical emergencies and research exceptions are separate matters. AMA guidance permits urgently necessary treatment without prior consent when the patient cannot participate and no surrogate is available, with subsequent disclosure and consent for ongoing treatment. Research exceptions require additional safeguards. An institutional review board may approve specified waivers or alterations, but waiving signed documentation is not equivalent to waiving the consent process itself. (code-medical-ethics.ama-assn.org)
Continuing consent and electronic formats
Research consent can continue beyond enrollment as new information becomes relevant to participation. Electronic informed consent may use text, diagrams, narration, video, and electronic signatures, either alongside or instead of paper methods. Such systems must still provide understandable information and opportunities for questions; responsibility remains with investigators rather than the software. Accessibility, identity verification where required, and data privacy are additional considerations. A digital signature records authorization but does not, by itself, establish comprehension or voluntariness. (hhs.gov)